Baidu’s Qianwen (千问) upgrades photo-based health inquiry to “reason like a doctor,” it has been reported

Upgrade gives Qianwen new multimodal reasoning in consultations

Baidu (百度)’s large model Qianwen (千问) has reportedly upgraded its “photo-based health inquiry” capability, enabling the system to interpret patient photos and produce step-by-step clinical reasoning akin to a doctor during consultations. It has been reported that the feature can flag visual signs, suggest differential diagnoses, propose next-step tests or referrals, and articulate the reasoning chain that led to each suggestion — all in natural language aimed at patient-facing scenarios.

How it works — and what’s unconfirmed

Details remain limited and some technical claims are unverified. Reportedly, the upgrade combines an improved visual encoder with medical knowledge retrieval and rule-based safeguards to prioritize safety. Baidu has been building multimodal stacks across search, cloud and health units; observers say Qianwen’s new capability likely draws on curated medical datasets and specialist workflows to generate more clinical-style outputs. It has been reported that the rollout will be phased and that human clinician oversight is intended in higher-risk scenarios.

Safety, regulation and geopolitical context

AI-driven medical advice is a high-stakes field. China has tightened rules around online medical services and algorithmic management in recent years, and any system offering diagnostic suggestions will face regulatory scrutiny and requirements for physician involvement and data protection. At the same time, the push to commercialize health AI in China comes amid fierce domestic competition — and broader geopolitical pressures such as export controls on high-end chips that are reshaping how Chinese firms design and deploy compute-heavy models.

What this means for patients and the market

If validated in clinical settings, the upgrade could speed triage, widen access to basic diagnostic support, and feed telemedicine platforms operated by Baidu and rivals such as Alibaba (阿里巴巴) and Tencent (腾讯). But can an algorithm safely “reason like a doctor” without formal clinical validation and oversight? That remains the key question for regulators, clinicians and patients as Qianwen’s new capability moves from lab demos into real-world consultations.